ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Institut Bergonié at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Institut Bergonié takes part in 5 sessions at ESMO 2026 in Madrid. Its work spans lung, breast and rare cancers, with attention to treatment and tumour profiling. Topics include using circulating tumour DNA at diagnosis to guide care in advanced lung cancer and genomic features of triple-negative breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Institut Bergonié Bordeaux, France | |
Regional comprehensive cancer centre of the French Unicancer network in Bordeaux, France. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Molecular landscape of triple-negative androgen receptor-positive breast cancer: Genomic analysis of tumours from patients enrolled in the phase II START trial Breast cancerBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 CIRCULAR: Implementing circulating tumor DNA (ctDNA) analysis at initial diagnosis improves management of advanced non-small cell lung cancer patients (NSCLC) Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Satellite Mon Oct 26 13:25–13:50 Real-world experience: Challenges & strategies in treating DTs Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Institut Bergonié
Tell us what you sell and we’ll find the people at Institut Bergonié most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction